Serum bilirubin and hepatic enzyme induction.
作者信息
Scott A K, Jeffers T A, Petrie J C, Gilbert J C
出版信息
Br Med J. 1979 Aug 4;2(6185):310. doi: 10.1136/bmj.2.6185.310.
Abstract
摘要
相似文献
1
Serum bilirubin and hepatic enzyme induction.血清胆红素与肝酶诱导
Br Med J. 1979 Aug 4;2(6185):310. doi: 10.1136/bmj.2.6185.310.
2
[Serum beta-glucuronidase activity in patients treated with phenobarbital and diphenylhydantoin].
Arch Farmacol Toxicol. 1982 Apr;8(1):37-44.
3
4
5
6
Effect of phenobarbital on liver functions in patients with Dubin-Johnson syndrome.
Gastroenterology. 1974 Aug;67(2):303-8.
7
Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
J Pharmacol Exp Ther. 1994 Jul;270(1):348-55.
8
Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker.以4β-羟基胆固醇作为生物标志物比较酶诱导型抗癫痫药物的CYP3A4诱导能力
Ther Drug Monit. 2018 Aug;40(4):463-468. doi: 10.1097/FTD.0000000000000518.
9
5,5'-Diphenyl-2-thiohydantoin (DPTH): an inducer of microsomal drug-metabolizing enzymes.5,5'-二苯基-2-硫代乙内酰脲（DPTH）：微粒体药物代谢酶的诱导剂。
J Pharmacol Exp Ther. 1972 Sep;182(3):491-9.
10
Increased metabolism of metyrapone in rats pretreated with diphenylhydantoin or phenobarbital.
Endocrinology. 1969 Sep;85(3):575-6. doi: 10.1210/endo-85-3-575.
引用本文的文献
1
Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias.急性卟啉病中药物致卟啉原性预测及药物处方指南。
Br J Clin Pharmacol. 2007 Nov;64(5):668-79. doi: 10.1111/j.0306-5251.2007.02955.x. Epub 2007 Jun 19.
2
Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.预防性抗惊厥治疗对大剂量白消安药代动力学的影响。
Cancer Chemother Pharmacol. 1993;33(3):181-6. doi: 10.1007/BF00686213.
3
Oxazepam pharmacokinetics in patients with epilepsy treated long-term with phenytoin alone or in combination with phenobarbitone.长期单用苯妥英或联合苯巴比妥治疗的癫痫患者中奥沙西泮的药代动力学
Br J Clin Pharmacol. 1983 Oct;16(4):441-4. doi: 10.1111/j.1365-2125.1983.tb02193.x.
4
Assessment of the drug metabolism capacity of the liver.肝脏药物代谢能力的评估。
Br J Clin Pharmacol. 1982 Nov;14(5):631-51. doi: 10.1111/j.1365-2125.1982.tb04950.x.
5
Does a selective 5-hydroxytryptamine antagonist (ICI 169, 369) lower blood pressure in hypertensive patients?选择性5-羟色胺拮抗剂（ICI 169, 369）能否降低高血压患者的血压？
Br J Clin Pharmacol. 1989 Apr;27(4):417-21. doi: 10.1111/j.1365-2125.1989.tb05388.x.
本文引用的文献
1
The fate of antipyrine in man.安替比林在人体内的代谢情况。
J Pharmacol Exp Ther. 1950 Jan;98(1):97-104.
2
Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man.尿中D-葡糖二酸排泄量作为人体肝酶诱导作用的一项检测指标。
Lancet. 1971 Mar 20;1(7699):572-5. doi: 10.1016/s0140-6736(71)91166-4.
Zotero 插件